Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
Immunological Reviews
|
July 15, 2009
Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration
Robert Sackstein
Frontiers in Immunology
|
January 29, 2019
The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering
Robert Sackstein
Stem Cells (Dayton, Ohio)
|
November 8, 2024
Enforced HCELL expression: empowering "Step 1" to optimize the efficacy of mesenchymal stem/stromal cell therapy for stroke and other clinical conditions
Robert Sackstein
Glycobiology
|
March 3, 2016
Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology
Robert Sackstein
Glycobiology
|
April 29, 2016
Translational glycobiology: Patient-oriented glycoscience research
Robert Sackstein
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2006
A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease
Robert Sackstein
Annals of the New York Academy of Sciences
|
February 23, 2012
Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution
Robert Sackstein
Current Opinion in Hematology
|
October 12, 2005
The lymphocyte homing receptors: gatekeepers of the multistep paradigm
Robert Sackstein
Current Opinion in Hematology
|
May 7, 2011
The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives
Robert Sackstein
Methods in Enzymology
|
September 7, 2010
Directing stem cell trafficking via GPS
Robert Sackstein
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
Immunological Reviews
|
July 15, 2009
Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration
Robert Sackstein
Frontiers in Immunology
|
January 29, 2019
The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering
Robert Sackstein
Stem Cells (Dayton, Ohio)
|
November 8, 2024
Enforced HCELL expression: empowering "Step 1" to optimize the efficacy of mesenchymal stem/stromal cell therapy for stroke and other clinical conditions
Robert Sackstein
Glycobiology
|
March 3, 2016
Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology
Robert Sackstein
Glycobiology
|
April 29, 2016
Translational glycobiology: Patient-oriented glycoscience research
Robert Sackstein
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2006
A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease
Robert Sackstein
Annals of the New York Academy of Sciences
|
February 23, 2012
Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution
Robert Sackstein
Current Opinion in Hematology
|
October 12, 2005
The lymphocyte homing receptors: gatekeepers of the multistep paradigm
Robert Sackstein
Current Opinion in Hematology
|
May 7, 2011
The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives
Robert Sackstein
Methods in Enzymology
|
September 7, 2010
Directing stem cell trafficking via GPS
Robert Sackstein
Page
of 11